Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.

Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, Kim S, Duru V, Bouchier C, Ma L, Lim P, Leang R, Duong S, Sreng S, Suon S, Chuor CM, Bout DM, Ménard S, Rogers WO, Genton B, Fandeur T, Miotto O, Ringwald P, Le Bras J, Berry A, Barale JC, Fairhurst RM, Benoit-Vical F, Mercereau-Puijalon O, Ménard D.

Nature. 2014 Jan 2;505(7481):50-5. doi: 10.1038/nature12876. Epub 2013 Dec 18.

2.

Mic1-3 Knockout Toxoplasma gondii is a good candidate for a vaccine against T. gondii-induced abortion in sheep.

Mévélec MN, Ducournau C, Bassuny Ismael A, Olivier M, Sèche E, Lebrun M, Bout D, Dimier-Poisson I.

Vet Res. 2010 Jul-Aug;41(4):49. doi: 10.1051/vetres/2010021. Epub 2010 Apr 13.

3.

A vaccine based on exosomes secreted by a dendritic cell line confers protection against T. gondii infection in syngeneic and allogeneic mice.

Beauvillain C, Ruiz S, Guiton R, Bout D, Dimier-Poisson I.

Microbes Infect. 2007 Nov-Dec;9(14-15):1614-22. Epub 2007 Jul 15.

PMID:
17905628
4.

The methylerythritol phosphate pathway for isoprenoid biosynthesis in coccidia: presence and sensitivity to fosmidomycin.

Clastre M, Goubard A, Prel A, Mincheva Z, Viaud-Massuart MC, Bout D, Rideau M, Velge-Roussel F, Laurent F.

Exp Parasitol. 2007 Aug;116(4):375-84. Epub 2007 Feb 21.

PMID:
17399705
5.

Generation of specific Th1 and CD8+ T-cell responses by immunization with mouse CD8+ dendritic cells loaded with HIV-1 viral lysate or envelope glycoproteins.

Aline F, Brand D, Bout D, Pierre J, Fouquenet D, Verrier B, Dimier-Poisson I.

Microbes Infect. 2007 Apr;9(4):536-43. Epub 2007 Jan 30.

PMID:
17350307
6.

Mic1-3 knockout of Toxoplasma gondii is a successful vaccine against chronic and congenital toxoplasmosis in mice.

Ismael AB, Dimier-Poisson I, Lebrun M, Dubremetz JF, Bout D, Mevelec MN.

J Infect Dis. 2006 Oct 15;194(8):1176-83. Epub 2006 Sep 11.

PMID:
16991094
7.

Induction of protective immunity against toxoplasmosis in mice by immunization with Toxoplasma gondii RNA.

Dimier-Poisson I, Aline F, Bout D, Mévélec MN.

Vaccine. 2006 Mar 6;24(10):1705-9. Epub 2005 Oct 10.

PMID:
16256251
8.

A novel CD4-CD8alpha+CD205+CD11b- murine spleen dendritic cell line: establishment, characterization and functional analysis in a model of vaccination to toxoplasmosis.

Ruiz S, Beauvillain C, Mévélec MN, Roingeard P, Breton P, Bout D, Dimier-Poisson I.

Cell Microbiol. 2005 Nov;7(11):1659-71.

PMID:
16207252
9.
10.

Synergistic role of micronemal proteins in Toxoplasma gondii virulence.

Cérède O, Dubremetz JF, Soête M, Deslée D, Vial H, Bout D, Lebrun M.

J Exp Med. 2005 Feb 7;201(3):453-63. Epub 2005 Jan 31.

11.
13.

Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection.

Aline F, Bout D, Amigorena S, Roingeard P, Dimier-Poisson I.

Infect Immun. 2004 Jul;72(7):4127-37.

14.

The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis.

Ismael AB, Sekkai D, Collin C, Bout D, Mévélec MN.

Infect Immun. 2003 Nov;71(11):6222-8.

15.

Protective mucosal Th2 immune response against Toxoplasma gondii by murine mesenteric lymph node dendritic cells.

Dimier-Poisson I, Aline F, Mévélec MN, Beauvillain C, Buzoni-Gatel D, Bout D.

Infect Immun. 2003 Sep;71(9):5254-65.

16.

[Vaccines on mucosal surfaces].

Bout D, Mévélec MN, Velge-Roussel F, Dimier-Poisson I, Lebrun M.

Arch Pediatr. 2003 Jun;10(6):565-70. Review. French. No abstract available.

PMID:
12915029
17.

Prospects for a human Toxoplasma vaccine.

Bout DT, Mevelec MN, Velge-Roussel F, Dimier-Poisson I, Lebrun M.

Curr Drug Targets Immune Endocr Metabol Disord. 2002 Oct;2(3):227-34. Review.

PMID:
12476487
18.

The Toxoplasma gondii protein MIC3 requires pro-peptide cleavage and dimerization to function as adhesin.

Cérède O, Dubremetz JF, Bout D, Lebrun M.

EMBO J. 2002 Jun 3;21(11):2526-36.

19.

Establishment and characterization of partially differentiated chicken enterocyte cell clones.

Velge P, Bottreau E, Quéré P, Pardon P, Nicolle JC, Morisson M, Bout D, Dimier I.

Eur J Cell Biol. 2002 Apr;81(4):203-12.

PMID:
12018388
21.

[Identification and molecular characterization of a Toxoplasma gondii microneme].

Cérède O, Garcia-Réguet N, Conseil V, Bout D, Dubremetz JF, Lebrun M.

Ann Pharm Fr. 2001 Sep;59(5):293-6. French.

PMID:
11787421
22.

Immunogenicity of synthetic peptides from the Sm31 antigen (cathepsin B) of the Schistosoma mansoni adult worms.

Noya O, De Noya BA, Ballen DE, Bermúdez H, Bout D, Hoebeke J.

Parasite Immunol. 2001 Nov;23(11):567-73.

23.

Anti-SAG1 peptide antibodies inhibit the penetration of Toxoplasma gondii tachyzoites into enterocyte cell lines.

Velge-Roussel F, Dimier-Poisson I, Buzoni-Gatel D, Bout D.

Parasitology. 2001 Sep;123(Pt 3):225-33.

PMID:
11578086
24.

Alterations in tumorigenicity of embryonal carcinoma cells by IGF-I triple-helix induced changes in immunogenicity and apoptosis.

Ly A, Francois JC, Upegui-Gonzalez LC, Swiercz B, Bedel C, Duc HT, Bout D, Trojan J.

Life Sci. 2000 Dec 8;68(3):307-19.

PMID:
11191646
25.

The microneme protein MIC3 of Toxoplasma gondii is a secretory adhesin that binds to both the surface of the host cells and the surface of the parasite.

Garcia-Réguet N, Lebrun M, Fourmaux MN, Mercereau-Puijalon O, Mann T, Beckers CJ, Samyn B, Van Beeumen J, Bout D, Dubremetz JF.

Cell Microbiol. 2000 Aug;2(4):353-64.

PMID:
11207591
26.

Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii.

Bonenfant C, Dimier-Poisson I, Velge-Roussel F, Buzoni-Gatel D, Del Giudice G, Rappuoli R, Bout D.

Infect Immun. 2001 Mar;69(3):1605-12.

27.

Enzyme activities in Schistosoma mansoni soluble egg antigen.

Cesari IM, Ballen DE, Perrone T, Oriol O, Hoebeke J, Bout D.

J Parasitol. 2000 Oct;86(5):1137-40.

PMID:
11128495
28.
29.

Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments.

Velge-Roussel F, Marcelo P, Lepage AC, Buzoni-Gatel D, Bout DT.

Infect Immun. 2000 Feb;68(2):969-72.

30.

Interaction between Toxoplasma gondii and enterocyte.

Bout D, Moretto M, Dimier-Poisson I, Gatel DB.

Immunobiology. 1999 Dec;201(2):225-8. Review.

PMID:
10631571
31.

Nasal immunization of mice with Cryptosporidium parvum DNA induces systemic and intestinal immune responses.

Sagodira S, Iochmann S, Mevelec MN, Dimier-Poisson I, Bout D.

Parasite Immunol. 1999 Oct;21(10):507-16.

33.

Protection of kids against Cryptosporidium parvum infection after immunization of dams with CP15-DNA.

Sagodira S, Buzoni-Gatel D, Iochmann S, Naciri M, Bout D.

Vaccine. 1999 May 14;17(19):2346-55.

PMID:
10392616
34.

Comparison of the humoral and cellular immune responses to two preparations of Cryptosporidium parvum CP15/60 recombinant protein.

Iochmann S, Sagodira S, Mévélec MN, Répérant JM, Naciri M, Coursaget P, Bout D.

Microb Pathog. 1999 Jun;26(6):307-15.

PMID:
10343059
35.

Purification and characterization of two alpha-amylases from Toxoplasma gondii.

Ferrer A, Hoebeke J, Bout D.

Exp Parasitol. 1999 May;92(1):64-72.

PMID:
10329367
36.

Intraepithelial lymphocytes traffic to the intestine and enhance resistance to Toxoplasma gondii oral infection.

Buzoni-Gatel D, Debbabi H, Moretto M, Dimier-Poisson IH, Lepage AC, Bout DT, Kasper LH.

J Immunol. 1999 May 15;162(10):5846-52.

37.

Salbutamol as an adjuvant for nasal vaccination.

Fermin Z, Bout D, Ricciardi-Castagnoli P, Hoebeke J.

Vaccine. 1999 Apr 9;17(15-16):1936-41.

PMID:
10217592
39.

Gut-derived intraepithelial lymphocytes induce long term immunity against Toxoplasma gondii.

Lepage AC, Buzoni-Gatel D, Bout DT, Kasper LH.

J Immunol. 1998 Nov 1;161(9):4902-8.

41.

Murine dendritic cells pulsed in vitro with Toxoplasma gondii antigens induce protective immunity in vivo.

Bourguin I, Moser M, Buzoni-Gatel D, Tielemans F, Bout D, Urbain J, Leo O.

Infect Immun. 1998 Oct;66(10):4867-74.

42.

Specificity of the solid phase alkaline phosphatase immunocapture assay for the diagnosis of human Schistosoma mansoni infection.

Cesari IM, Ferrer A, Kombila M, Pichard E, Decam C, Qiu LS, Bout D, Richard-Lenoble D.

Trans R Soc Trop Med Hyg. 1998 Jan-Feb;92(1):38-9.

PMID:
9692147
44.

Mapping of B epitopes in GRA4, a dense granule antigen of Toxoplasma gondii and protection studies using recombinant proteins administered by the oral route.

Mévélec MN, Mercereau-Puijalon O, Buzoni-Gatel D, Bourguin I, Chardès T, Dubremetz JF, Bout D.

Parasite Immunol. 1998 Apr;20(4):183-95.

45.

Differences in immunological response to a T. gondii protein (SAG1) derived peptide between two strains of mice: effect on protection in T. gondii infection.

Velge-Roussel F, Moretto M, Buzoni-Gatel D, Dimier-Poisson I, Ferrer M, Hoebeke J, Bout D.

Mol Immunol. 1997 Oct;34(15):1045-53.

PMID:
9519763
46.
47.

Adoptive transfer of gut intraepithelial lymphocytes protects against murine infection with Toxoplasma gondii.

Buzoni-Gatel D, Lepage AC, Dimier-Poisson IH, Bout DT, Kasper LH.

J Immunol. 1997 Jun 15;158(12):5883-9.

PMID:
9190941
48.

Cell mediated immunity induced in mice by HPV 16 L1 virus-like particles.

Dupuy C, Buzoni-Gatel D, Touze A, Le Cann P, Bout D, Coursaget P.

Microb Pathog. 1997 Apr;22(4):219-25.

PMID:
9140917
49.

Immunochemical characterization of antibody-coated nanoparticles.

Velge-Roussel F, Breton P, Guillon X, Lescure F, Bru N, Bout D, Hoebeke J.

Experientia. 1996 Aug 15;52(8):803-6.

PMID:
8774752

Supplemental Content

Support Center